|
| Friday, 20 May 2016, 15:00 HKT/SGT | |
| |  | |
Source: A*STAR | |
|
|
|
|
| New insights to differences in preimplantation embryonic cells bring to light the importance of microscopic analysis in assisted reproduction procedures |
SINGAPORE, May 20, 2016 - (ACN Newswire) - Researchers at A*STAR's Institute of Molecular and Cell Biology (IMCB) have developed advanced microscopy technologies to monitor embryo development in real time, revealing how mammalian cells differentiate during the earliest stages of embryonic life. These findings, coupled with the novel imaging technique, hold great potential in shaping how assisted reproduction procedures such as In-Vitro Fertilisation (IVF)[1] and Preimplantation Genetic Diagnosis (PGD)[2] are performed, and making these procedures more effective.
Across the globe, more women are relying on assisted reproduction procedures. Singapore alone, for example, has carried out over 6000 assisted reproduction cycles in 2015, an increase of more than 1000 cycles from 2012[3].
Current IVF procedures assess whether an embryo is suitable for implantation into the mother largely through observable measurements such as gauging if the rate of growth of the embryo is normal. PGD of embryos, on the other hand, is carried out by analysing a randomly extracted embryonic cell for genetic defects, with the assumption that all cells within a preimplantation embryo are identical and that the removal of a single embryonic cell would not affect the overall development of the embryo after implantation.
Contrary to the current conception that every cell within a preimplantation embryo is identical, the team of researchers at IMCB has demonstrated that the cells are in fact differentiated and may play very different roles in later development. By designing new cutting-edge real-time imaging techniques, the researchers were able to examine every cell within a preimplantation mouse embryo without perturbing its development. They observed differences in the way which certain proteins in each cell bind to their target genes. The scientists also observed that there were variances in cell behaviour at every stage of the embryo's development. As mouse embryos bear strong resemblance to human embryos at early stage development, the findings indicate that cells within a preimplantation human embryo are also not identical.
The study, therefore, refines our understanding of early stage embryonic development and highlights how assisted reproduction procedures such as IVF and PGD may be further enhanced to ensure successful fertilisation, smooth pregnancy and childbirth. Further development of the real-time imaging technique may eventually enable fertility specialists to study the microscopic properties of embryos and decide more precisely if an embryo is suitable for implantation, or screen an embryo for genetic abnormalities using imaging lasers instead of physical manipulation. This would enable better quality control of embryos implanted in mothers hence potentially increasing the chances of success for these procedures through more efficient control of embryo quality.
Dr Nicolas Plachta, Senior Principal Investigator of IMCB, said, "Most laboratories conduct studies on embryonic cells via invasive methods which do not keep the embryo alive. Our lab is the only one in the world imaging single cells in live mammalian embryos at the quantitative level, which allows us to observe every cell within an embryo at every stage of its development. Our findings as a result of this advanced technique have put forth a new paradigm of knowledge that would encourage more detailed microscopic analysis for future assisted reproduction procedures."
Dr Sadhana Nadarajah, Director of KKIVF Centre and Senior Consultant, Department of Reproductive Medicine, KK Women's and Children's Hospital, said, "This novel method of screening embryos is indeed exciting. If it can be successfully used on human embryos, without affecting its successive growth, it will improve the technique of embryo selection in IVF."
Prof Hong Wanjin, Executive Director of IMCB, said, "In many developed countries like Singapore, women are having children later in their lives, which has been linked to declined fertility. As such, assisted reproduction procedures needs to be constantly improved and made more reliable to help women successfully conceive and sustain a healthy birth rate. Nicolas and his dedicated team of researchers have therefore made a significant breakthrough that could benefit the society greatly."
The study was published in the top-tier scientific journal, Cell, and was also featured as the cover of the journal.
[1] In-Vitro Fertilisation (IVF) is a procedure in which eggs (ova) from a woman's ovary are removed and fertilised with sperm in a laboratory procedure, and then the fertilised egg (embryo) is returned to the woman's uterus.
[2] Preimplantation Genetic Diagnosis (PGD) is a screening test used to determine if genetic or chromosomal disorders are present in embryos produced through IVF.
[3] The Straits Times: http://bit.ly/255diMg
The research findings described in this media release can be found in the Cell Journal, under the title, "Long-Lived Binding of Sox2 to DNA Predicts Cell Fate in the Four-Cell Mouse Embryo" by Melanie D. White 1,3, Juan Francisco Angiolini 2,3, Yanina D. Alvarez 2,3, Gurpreet Kaur 1,3, Ziqing W. Zhao 1, Esteban Mocskos 2, Luciana Bruno 2, Stephanie Bissiere 1, Valeria Levi 2,*, Nicolas Plachta 1,*.
1 Institute of Molecular and Cell Biology, A*STAR, 61 Biopolis Drive, Singapore 138673, Singapore
2 Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, CONICET, Buenos Aires, C1428EHA, Argentina
3 Equal contributions
Correspondence: V.L. (vlevi12@gmail.com); N.P. (plachtan@imcb.a-star.edu.sg)
Image: "Microscopic image of a four-cell mouse embryo" (Credit-Dr Nicolas Plachta)
About the Institute of Molecular and Cell Biology (IMCB)
The Institute of Molecular and Cell Biology (IMCB) was launched on 23 January 1985, with its official opening ceremony held on 2 October 1987 at the National University of Singapore (NUS). It subsequently became an autonomous research institute (RI) of A*STAR, moving to Biopolis in 2004. IMCB's vision is to be a premier cell and molecular biology institute which addresses the mechanistic basis of human diseases and its mission is to conduct cutting-edge discovery research in disease pathways; to groom early career researchers to be future leaders in research; and to collaborate with medical and industry communities for research impact. IMCB plays an important role training and recruiting scientific talents, and has contributed to the development of other research entities in Singapore. Its success in fostering a biomedical research culture in Singapore has catalysed Singapore's transformation into an international hub for biomedical research, development and innovation. For more information about IMCB, visit www.imcb.a-star.edu.sg.
Contact:
Tan Yun Yun
Senior Officer, Corporate Communications
Agency for Science, Technology and Research
Tel: +65 6826 6273
Email: tan_yun_yun@a-star.edu.sg
Topic: Research and development
Source: A*STAR
Sectors: Science & Research, BioTech, BioTech, Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| A*STAR |
| Dec 6, 2022 14:00 HKT/SGT |
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
| June 2, 2022 21:00 HKT/SGT |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| June 2, 2022 21:00 HKT/SGT |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| Sept 30, 2021 16:00 HKT/SGT |
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
| July 31, 2020 08:00 HKT/SGT |
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
| July 24, 2020 17:00 HKT/SGT |
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
| Oct 22, 2019 04:00 HKT/SGT |
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| June 28, 2019 08:00 HKT/SGT |
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
| Apr 5, 2019 18:00 HKT/SGT |
|
Passing of Dr Sydney Brenner, Nobel Laureate, Renowned Pioneer in Molecular Biology, A*Star Senior Fellow |
| Jan 21, 2019 13:00 HKT/SGT |
|
Branched-Chain Amino Acids Found to Regulate the Development and Progression of Cancer |
| More news >> |
 |
|
|
|
